The site uses anonymous third party analytic cookies: in accessing any element/area of the site outside of this banner, you consent to receiving cookies.

Value add: using digital engagement metrics to optimise and drive salesforce effectiveness

In the final part of the Smarter Strategies series, Wilmington Healthcare’s Simon Grime describes the key steps in measuring the value of your...

Strictly personal: how to deliver 360-degree engagement to support your organisation’s agility and impact

In the second of our three-part Smarter Strategies series, Wilmington Healthcare’s Simon Grime takes a practical look at how to use a 360-degree...

Why pharma must get smart in its approach to customer engagement

In the first of our three-part Smarter Strategies series, Wilmington Healthcare’s Simon Grime considers how pharma can now perfect the use of good...

What’s happening with value-based procurement?

Oli Hudson, content director at Wilmington Healthcare, looks at the phrase of the moment in procurement circles – what does it actually mean for...

Getting to grips with population health

Improving population health outcomes is one of the defining missions of new integrated care systems, but what does this mean for industry Wilmington...

Changing faces: Understanding the key customer contact points within the ICS landscape

As well as creating new structures, the reforms underway within the NHS will see a considerable movement of people and power across the new...

A new era for Medicines Funding: How will NHS reforms affect pharmaceutical companies?

Wilmington Healthcare’s Oli Hudson explains how the drug funding landscape is changing and what industry must do to adapt Who pays for what in...

Negotiating the changing NHS landscape: the five critical shifts the pharma industry must embrace

As the long-awaited Health and Care Bill begins its passage through parliament, Oli Hudson looks at five critical changes resulting from these...

What does integration mean for NHS-Industry partnership?

Johnny Skillicorn-Aston and James Roach of Conclusio look at what this means for Pharma and the NHS Conclusio has a long-held the view that...

Building trust in the Covid-19 recovery era

Simon Grime of Wilmington Healthcare, explores how pharma can strengthen existing relationships and form new ones in an NHS customer environment that...

How to embrace digital engagement, intelligently

By Simon Grime, Director - Digital Engagement, Wilmington Healthcare Covid has changed the landscape for customer engagement so now it’s time to...

Integrated NHS finances: what do they mean for High Cost Drugs?

Oli Hudson and Steve How, of Wilmington Healthcare, explore NHS England’s new system-level funding and its impact on prescribing for High Cost...

Covid-19: How is it affecting prescribing patterns?

Oli Hudson, Content Director at Wilmington Healthcare, analyses prescribing data in three key disease areas In common with many other aspects of...

Covid, service change and the NHS Reset: Just how can industry keep up?

In this on-demand article, first published in November 2020, Oli Hudson, Content Director at Wilmington Healthcare, looks at the current onslaught of...